A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.
about
Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipidsIntradermal administration of RiVax protects mice from mucosal and systemic ricin intoxicationThermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.Ricinus communis intoxications in human and veterinary medicine-a summary of real cases.The need for continued development of ricin countermeasures.Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates.A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate.LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunityStabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells.Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality.Rational design of heat stable lyophilized rotavirus vaccine formulations
P2860
Q28476692-019ED5F1-515E-4CFC-884E-CE20E4AB08F1Q34012394-E330829F-9B16-4D28-8D4F-68421F3E35A9Q35229553-F25F1DEA-9BC5-4ED0-B722-874A8787EB8AQ35534490-3FA3937F-1C0A-4E62-B6DC-DD4F740C0030Q35866996-4A3D13A7-0088-49F4-A171-285F91C022BDQ35947693-C1B93C74-8FD2-43BD-B208-EB73043F96ABQ36977852-8489AD74-6DAB-4AF3-9492-D4B5C8282108Q37066634-093C1730-1922-4707-AF7C-A50BF80383F6Q37231025-512722C8-E157-4D00-8552-1E4783ACC88FQ39655377-A0D330EE-6BE3-42FB-8F4A-815F94D75DF8Q40722407-8B94AF5D-07B3-40C9-84A9-3B888E215031Q50113262-45DECA17-C3E1-4B67-B731-83DF159AC131Q57922635-5321ADDD-EEAA-4682-98F6-6ACE11053CE2
P2860
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@ast
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@en
type
label
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@ast
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@en
prefLabel
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@ast
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@en
P2860
P1433
P1476
A lyophilized formulation of R ...... ccine, retains immunogenicity.
@en
P2093
Ellen S Vitetta
Joan E Smallshaw
P2860
P304
P356
10.1016/J.VACCINE.2009.12.081
P407
P577
2010-01-12T00:00:00Z